Mark Ultsch
9Patents
2h-index
15Co-inventors
48Inventor score
Filing activity: Sep 29, 1993 → May 26, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5506107A | Selecting ligand agonists and antagonists | Physics | 78 | Expired |
| US7084240B2 | Crystallization of IGF-1 | Chemistry; Metallurgy | 4 | Expired |
| US7238658B2 | Crystallization of IGF-1 | Chemistry; Metallurgy | 1 | Expired |
| US7596455B2 | Crystallization of IGF-1 | Chemistry; Metallurgy | 0 | Active |
| US7354769B2 | Crystallization of IGF-1 | Chemistry; Metallurgy | 0 | Active |
| US11034725B2 | Compositions and methods for treating cardiovascular disease | Physics | 0 | Active |
| US7433788B2 | Crystallization of IGF-1 | Chemistry; Metallurgy | 0 | Active |
| US7297763B2 | Crystallization of IGF-1 | Chemistry; Metallurgy | 0 | Active |
| US10787484B2 | Compositions and methods for treating cardiovascular disease | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.